Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 1.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.56 | 1.36 |
NAV | ₹123.13 | ₹200.81 |
Fund Started | 30 Aug 1994 | 07 May 2007 |
Fund Size | ₹128.58 Cr | ₹84854.73 Cr |
Exit Load | Exit load of 1% if redeemed within 365 days. | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 0.16% | 6.72% |
3 Year | 17.07% | 24.76% |
5 Year | 20.32% | 28.71% |
1 Year
3 Year
5 Year
Equity | 97.11% | 93.60% |
Cash | 2.89% | 6.40% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Pace Digitek Ltd. | 4.67% |
Coforge Ltd. | 4.09% |
Linde India Ltd. | 3.95% |
Bank of India | 3.85% |
Dalmia Bharat Ltd. | 3.78% |
Regaal Resources Ltd. | 3.70% |
LIC Housing Finance Ltd. | 3.67% |
Container Corporation Of India Ltd. | 3.58% |
Hindustan Petroleum Corporation Ltd. | 3.55% |
Aurobindo Pharma Ltd. | 3.46% |
Name | Assets |
|---|---|
Max Financial Services Ltd. | 4.76% |
Balkrishna Industries Ltd. | 3.54% |
Indian Bank | 3.26% |
Fortis Healthcare Ltd. | 3.18% |
AU Small Finance Bank Ltd. | 3.16% |
Coforge Ltd. | 2.93% |
The Federal Bank Ltd. | 2.91% |
Hindustan Petroleum Corporation Ltd. | 2.90% |
Glenmark Pharmaceuticals Ltd. | 2.87% |
Ipca Laboratories Ltd. | 2.80% |
Name | Hardik Shah | Chirag Setalvad |
Start Date | 13 Jun 2023 | 28 Jun 2014 |
Name
Start Date
Description | The Scheme seeks to achieve long term capital appreciation by investing in a portfolio consisting of equity and equity related securities predominantly of mid cap companies. | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. |
Launch Date | 30 Aug 1994 | 07 May 2007 |
Description
Launch Date